Capricor Therapeutics Inc...

NASDAQ: CAPR · Real-Time Price · USD
7.96
0.18 (2.31%)
At close: Aug 15, 2025, 3:59 PM
7.93
-0.31%
After-hours: Aug 15, 2025, 05:13 PM EDT

Capricor Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-40.47M -22.29M -29.02M -20.02M
Depreciation & Amortization
1.43M 1.07M 533.13K 245.7K
Stock-Based Compensation
9.77M 7.39M 4.46M 2.97M
Other Working Capital
-12.73M -3.25M 27.54M -808.83K
Other Non-Cash Items
65.54K -18.24K 196.01K 129.73K
Deferred Income Tax
n/a n/a n/a -310.25K
Change in Working Capital
-10.78M -11.75M 28.75M 182.34K
Operating Cash Flow
-40M -25.6M 4.92M -16.81M
Capital Expenditures
-1.54M -2.05M -3.36M -1.2M
Cash Acquisitions
n/a n/a 1.36B n/a
Purchase of Investments
-208.44M -97.44M -114.22M n/a
Sales Maturities Of Investments
93.8M 104.6M 82.51M n/a
Other Investing Acitivies
n/a n/a -1.36B n/a
Investing Cash Flow
-116.18M 5.11M -35.07M -1.2M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
450.17K 64.6K 70.3K 50.56K
Financial Cash Flow
152.77M 25.58M 4.87M 20.23M
Net Cash Flow
-3.41M 5.09M -25.28M 2.22M
Free Cash Flow
-41.53M -27.64M 1.56M -18.01M